3rd Quarter - Report

T1INTERNATIONAL USA for T1INTERNATIONAL USA

Firm
Client
Income
—
Expenses
—

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to the following bills: oBig Beautiful Bill (HR 1) oDrug Competition Enhancement Act (S.1040) oAffordable Prescriptions for Patients Act (S.1041) oStop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics (Stop STALLING) Act (S.1095) oPreserve Access to Affordable Generics and Biosimilars Act (S.1096) oPromoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act (H.R.3160/S.1553): oPatent Eligibility Restoration (PERA) Act (H.R.3152/S.1546) oPrescription Drug Price Relief Act (S.1818) oEnd Price Gouging for Medications Act (S.1753) oFair Prescription Drug Prices for Americans Act (S.1218)

LobbyistCovered position, as disclosed
ALLISON HARDT —
SHAINA KASPER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1 (119th), S. 1218 (119th), S. 1095 (119th), S. 1553 (119th), S. 1041 (119th), S. 1818 (119th), H.R. 3152 (119th), S. 1753 (119th), H.R. 3160 (119th), S. 1096 (119th), S. 1040 (119th), S. 1546 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.